NextGen Healthcare (NXGN) Misses Q4 EPS by 1c; Offers FY22 Guidance

May 17, 2022 4:09 PM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

NextGen Healthcare (NASDAQ: NXGN) reported Q4 EPS of $0.19, $0.01 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $151.3 million versus the consensus estimate of $148.17 million.


NextGen Healthcare sees FY2023 EPS of $0.95-$1.01, versus the consensus of $0.98. NextGen Healthcare sees FY2023 revenue of $628-640 million, versus the consensus of $595 million.

For earnings history and earnings-related data on NextGen Healthcare (NXGN) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities